Karen Bjerg Pedersen

Karen Bjerg Pedersen

Klinisk lektor


Udgivelsesår:
  1. 2022
  2. Udgivet

    Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

    Self, W. H., Sandkovsky, U., Reilly, C. S., Vock, D. M., Gottlieb, R. L., Mack, M., Golden, K., Dishner, E., Vekstein, A., Ko, E. R., Der, T., Franzone, J., Almasri, E., Fayed, M., Filbin, M. R., Hibbert, K. A., Rice, T. W., Casey, J. D., Hayanga, J. A., Badhwar, V., Leshnower, B. G., Sharifpour, M., Knowlton, K. U., Peltan, I. D., Bakowska, E., Kowalska, J., Bowdish, M. E., Sturek, J. M., Rogers, A. J., Files, D. C., Mosier, J. M., Gong, M. N., Douin, D. J., Hite, R. D., Trautner, B. W., Jain, M. K., Jensen , Jens-Ulrik Stæhr , Clausen, C. L., Hovmand, N., Pedersen, Karen Bjerg, Thorlacius-Ussing, L., Tinggaard, M., Rastoder, E., Helleberg, Marie, Gerstoft, Jan, Lindegaard, Birgitte, Pedersen, T. I., Johnsen, Stine, Wiese, L., Knudsen, Lene Surland & ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, A. F. I. W. C. (. S. G., 2022, I: The Lancet Infectious Diseases. 22, 5, s. 622-635 14 s.

    Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

  3. 2021
  4. Udgivet

    Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

    Pelchen-Matthews, A., Larsen, J. F., Shepherd, L., Begovac, J., Pedersen, Karen Bjerg, De Wit, S., Horban, A., Jablonowska, E., Johnson, M., Khromova, I., Losso, M. H., Nielsen, L. N., Ridolfo, A. L., Schmied, B., Stephan, C., Yust, I., Curtis, L., Vannappagari, V., Ragone, L., Roen, A., Raben, D., Kirk, Ole, Peters, L., Mocroft, A. & for the EuroSIDA study group, F. T. E. S. G., 2021, I: HIV Research and Clinical Practice. 22, 6, s. 160-168

    Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

ID: 283276421